BOSTON COMMON ASSET MANAGEMENT, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
BOSTON COMMON ASSET MANAGEMENT, LLC portfolio value:
$37.12M
portfolio value
BOSTON COMMON ASSET MANAGEMENT, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.32% | -5.53K shares | 1.99M | $688.87 | 53.89K |
| Q2 2022 | share | Increase | +39.12% | 16.71K shares | 5.29M | $591.13 | 59.43K |
| Q1 2022 | share | Increase | +1.54% | 647 shares | 3.26M | $698.42 | 42.71K |
| Q4 2021 | share | Increase | +0.75% | 312 shares | 1.29M | $642.51 | 42.07K |
| Q3 2021 | share | Increase | +0.45% | 189 shares | 2.05M | $605.18 | 41.76K |
| Q2 2021 | share | Increase | +65.59% | 16.46K shares | 11.34M | $558.54 | 41.57K |
| Q1 2021 | share | Increase | +115.72% | 13.46K shares | 6.25M | $473.14 | 25.10K |
| Q4 2020 | share | Increase | +4.83% | 536 shares | -593K | $483.11 | 11.63K |
| Q3 2020 | share | Decrease | -0.50% | -56 shares | -744K | $559.78 | 11.10K |
| Q2 2020 | share | Decrease | -2.39% | -273 shares | 1.37M | $623.65 | 11.15K |
| Q1 2020 | share | Decrease | -28.00% | -4.44K shares | -379K | $488.29 | 11.43K |
| Q4 2019 | share | Decrease | -3.75% | -619 shares | 1.38M | $375.48 | 15.87K |
| Q3 2019 | share | Decrease | -3.90% | -670 shares | -797K | $277.4 | 16.49K |
| Q2 2019 | share | Increase | +33.40% | 4.29K shares | 90K | $313 | 17.16K |
| Q1 2019 | share | Decrease | -2.03% | -266 shares | 378K | $410.62 | 12.86K |
| Q4 2018 | share | Increase | +27.28% | 2.81K shares | 736K | $373.5 | 13.13K |
| Q3 2018 | share | Decrease | -10.27% | -1.18K shares | 202K | $404.04 | 10.31K |
| Q2 2018 | share | Decrease | -3.97% | -475 shares | -156K | $344.99 | 11.49K |
| Q1 2018 | share | Increase | +1.04% | 123 shares | -333K | $344.36 | 11.97K |
| Q4 2017 | share | Increase | +2.30% | 266 shares | -724K | $375.96 | 11.85K |
| Q3 2017 | share | Decrease | -0.73% | -85 shares | -552K | $447.12 | 11.58K |
| Q2 2017 | share | Decrease | -22.16% | -3.32K shares | -78K | $491.14 | 11.67K |
| Q1 2017 | share | Increase | +28.17% | 3.29K shares | 1.51M | $387.51 | 14.99K |
| Q4 2016 | share | Increase | +0.91% | 106 shares | -366K | $367.09 | 11.69K |
| Q3 2016 | share | Increase | +26.54% | 2.43K shares | 1.46M | $402.02 | 11.59K |
| Q2 2016 | share | Increase | +91.33% | 4.37K shares | 1.47M | $349.23 | 9.16K |
| Q1 2016 | share | Increase | 0.00% | 4.78K shares | 1.72M | $360.44 | 4.78K |